• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清铁蛋白作为埃及非酒精性脂肪性肝病患者肝纤维化预测的非侵入性标志物。

Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver disease.

作者信息

El Nakeeb Noha, Saleh Shereen A, Massoud Yasmine M, Hussein Ahmed, Hamed Rana

机构信息

Internal Medicine Department, Faculty of Medicine Ain Shams University Cairo Egypt.

Tropical Medicine Department, Faculty of Medicine Ain Shams University Cairo Egypt.

出版信息

JGH Open. 2017 Nov 13;1(3):112-119. doi: 10.1002/jgh3.12019. eCollection 2017 Nov.

DOI:10.1002/jgh3.12019
PMID:30483546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6207043/
Abstract

BACKGROUND AND AIM

Many studies have found a relationship between hepatic iron, serum ferritin, and non-alcoholic fatty liver disease (NAFLD) or its progress. The aim of this study is to assess the value of serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis in NAFLD.

METHODS

This study included 113 subjects who were classified into three groups. Group I included 30 healthy subjects as control with no clinical, radiological, and histological features of NAFLD. Group II included 31 NAFLD patients without hepatic fibrosis. Group III included 52 patients with hepatic fibrosis on top of NAFLD.

RESULTS

Serum ferritin was determined using ferritin ELISA kit. Fibrosis 4 score was calculated. Liver biopsy was conducted for included patients. Significantly higher levels of serum ferritin were found in patients with hepatic fibrosis on top of NAFLD than controls. Receiver operating characteristic curve analysis revealed that an optimum cutoff level of 51.95 ng/mL was the best to predict fibrosis on top of NAFLD with diagnostic sensitivity and specificity of 65% and 60%, respectively, and area under the curve = 0.658.

CONCLUSION

Higher serum ferritin was found in patients with hepatic fibrosis on top of NAFLD. Serum ferritin was found to be a predictor of fibrosis on top of NAFLD with moderate sensitivity and specificity.

摘要

背景与目的

许多研究发现肝脏铁、血清铁蛋白与非酒精性脂肪性肝病(NAFLD)及其进展之间存在关联。本研究旨在评估血清铁蛋白作为一种非侵入性标志物在预测NAFLD肝纤维化中的价值。

方法

本研究纳入113名受试者,分为三组。第一组包括30名健康受试者作为对照,无NAFLD的临床、影像学和组织学特征。第二组包括31名无肝纤维化的NAFLD患者。第三组包括52名除NAFLD外还患有肝纤维化的患者。

结果

使用铁蛋白ELISA试剂盒测定血清铁蛋白。计算纤维化4评分。对纳入的患者进行肝活检。除NAFLD外还患有肝纤维化的患者血清铁蛋白水平显著高于对照组。受试者工作特征曲线分析显示,最佳截断水平为51.95 ng/mL时,预测除NAFLD外的纤维化效果最佳,诊断敏感性和特异性分别为65%和60%,曲线下面积 = 0.658。

结论

除NAFLD外还患有肝纤维化的患者血清铁蛋白水平较高。血清铁蛋白被发现是除NAFLD外纤维化的一个预测指标,具有中等的敏感性和特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/6207043/d9d72b896072/JGH3-1-112-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/6207043/d2505fc1479b/JGH3-1-112-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/6207043/d9d72b896072/JGH3-1-112-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/6207043/d2505fc1479b/JGH3-1-112-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/6207043/d9d72b896072/JGH3-1-112-g002.jpg

相似文献

1
Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver disease.血清铁蛋白作为埃及非酒精性脂肪性肝病患者肝纤维化预测的非侵入性标志物。
JGH Open. 2017 Nov 13;1(3):112-119. doi: 10.1002/jgh3.12019. eCollection 2017 Nov.
2
Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution.血清铁蛋白在非酒精性脂肪性肝病患者肝纤维化评估中的临床应用:需谨慎进行。
Hepatol Res. 2014 Dec;44(14):E499-502. doi: 10.1111/hepr.12327. Epub 2014 Apr 10.
3
Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India.血清铁蛋白水平可预测印度非酒精性脂肪性肝病患者的组织学严重程度。
Indian J Gastroenterol. 2015 May;34(3):200-8. doi: 10.1007/s12664-015-0572-5. Epub 2015 Jun 25.
4
Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中纤维化的无创诊断
J Clin Exp Hepatol. 2012 Jun;2(2):145-55. doi: 10.1016/S0973-6883(12)60103-0. Epub 2012 Jul 21.
5
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease.评估血清铁蛋白和肝铁与非酒精性脂肪性肝病严重程度的相关性。
Liver Int. 2019 Jul;39(7):1325-1334. doi: 10.1111/liv.14096. Epub 2019 Mar 27.
6
Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.经活检证实的非酒精性脂肪性肝病患者血清可溶性凝集素样氧化型低密度脂蛋白受体-1水平升高。
World J Gastroenterol. 2015 Jul 14;21(26):8096-102. doi: 10.3748/wjg.v21.i26.8096.
7
Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis.血清β-促甲状腺素水平作为非酒精性脂肪性肝病和肝纤维化无创评估的新标志物。
Eur J Gastroenterol Hepatol. 2016 Jan;28(1):57-63. doi: 10.1097/MEG.0000000000000502.
8
FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients.FICK-3评分结合纤维化-4、胰岛素抵抗和细胞角蛋白-18预测埃及非酒精性脂肪性肝病患者的非酒精性脂肪性肝炎
Pak J Biol Sci. 2019 Jan;22(10):457-466. doi: 10.3923/pjbs.2019.457.466.
9
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.铜蓝蛋白基因变异与非酒精性脂肪性肝病患者的高血铁蛋白血症和肝脏铁含量增加有关。
J Hepatol. 2021 Sep;75(3):506-513. doi: 10.1016/j.jhep.2021.03.014. Epub 2021 Mar 24.
10
Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.血清细胞角蛋白-18及其与非酒精性脂肪性肝病和丙型肝炎病毒患者通过FibroScan诊断的肝纤维化及受控衰减参数测定的肝脂肪变性的关系。
Eur J Gastroenterol Hepatol. 2019 May;31(5):633-641. doi: 10.1097/MEG.0000000000001385.

引用本文的文献

1
Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC).探索代谢性高铁蛋白血症(MHF)在脂肪性肝病(SLD)和肝细胞癌(HCC)中的作用。
Cancers (Basel). 2025 Feb 28;17(5):842. doi: 10.3390/cancers17050842.
2
Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.非酒精性脂肪性肝病患者的循环铁蛋白:系统评价与荟萃分析
J Clin Exp Hepatol. 2024 May-Jun;14(3):101353. doi: 10.1016/j.jceh.2024.101353. Epub 2024 Feb 2.
3
Association between serum ferritin and liver stiffness in adults aged ≥20 years: A cross-sectional study based on NHANES.

本文引用的文献

1
Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease.白细胞计数与偶发性非酒精性脂肪性肝病发生之间的关联。
Gastroenterol Res Pract. 2016;2016:7653689. doi: 10.1155/2016/7653689. Epub 2016 Dec 13.
2
Insulin resistance in development and progression of nonalcoholic fatty liver disease.胰岛素抵抗在非酒精性脂肪性肝病发生发展中的作用
World J Gastrointest Pathophysiol. 2016 May 15;7(2):211-7. doi: 10.4291/wjgp.v7.i2.211.
3
Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.
血清铁蛋白与≥20 岁成年人肝脏硬度的相关性:基于 NHANES 的横断面研究。
Medicine (Baltimore). 2023 Sep 1;102(35):e34838. doi: 10.1097/MD.0000000000034838.
4
Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease.MiRNA-34a和MiRNA-192作为非酒精性脂肪性肝病危险因素的意义。
J Genet Eng Biotechnol. 2023 Feb 9;21(1):13. doi: 10.1186/s43141-023-00467-z.
5
Genetic effects of iron levels on liver injury and risk of liver diseases: A two-sample Mendelian randomization analysis.铁水平对肝损伤及肝脏疾病风险的遗传效应:一项两样本孟德尔随机化分析
Front Nutr. 2022 Sep 16;9:964163. doi: 10.3389/fnut.2022.964163. eCollection 2022.
6
Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review.血清铁蛋白水平与非酒精性脂肪性肝病各阶段之间的关联:一项系统评价。
Front Med (Lausanne). 2022 Aug 3;9:934989. doi: 10.3389/fmed.2022.934989. eCollection 2022.
7
Cutoff Values for Serum Ferritin in Predicting Cirrhosis Severity due to Cholestatic Jaundice in Vietnamese Children.血清铁蛋白在预测越南儿童胆汁淤积性黄疸所致肝硬化严重程度中的截断值。
Med Arch. 2022 Apr;76(2):122-126. doi: 10.5455/medarh.2022.76.122-126.
8
SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease.钠-葡萄糖协同转运蛋白 2 抑制剂作为影响非酒精性脂肪性肝病结局最有前途的影响因子。
Int J Mol Sci. 2022 Mar 27;23(7):3668. doi: 10.3390/ijms23073668.
9
Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease.血清铁状态生物标志物与非酒精性脂肪性肝病患者肝癌发展风险的关系。
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):230-235. doi: 10.1158/1055-9965.EPI-21-0754. Epub 2021 Oct 14.
10
The Role of Elastography in Non-Alcoholic Fatty Liver Disease.弹性成像在非酒精性脂肪性肝病中的作用
Curr Health Sci J. 2020 Jul-Sep;46(3):255-269. doi: 10.12865/CHSJ.46.03.07. Epub 2020 Sep 30.
非酒精性脂肪性肝病患者的铁状态与代谢综合征
Middle East J Dig Dis. 2016 Jan;8(1):31-8. doi: 10.15171/mejdd.2016.04.
4
Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies.体重指数与非酒精性脂肪性肝病风险:两项电子健康记录前瞻性研究
J Clin Endocrinol Metab. 2016 Mar;101(3):945-52. doi: 10.1210/jc.2015-3444. Epub 2015 Dec 16.
5
Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India.血清铁蛋白水平可预测印度非酒精性脂肪性肝病患者的组织学严重程度。
Indian J Gastroenterol. 2015 May;34(3):200-8. doi: 10.1007/s12664-015-0572-5. Epub 2015 Jun 25.
6
The clinical significance of serum ferritin in pediatric non-alcoholic Fatty liver disease.血清铁蛋白在儿童非酒精性脂肪性肝病中的临床意义
Pediatr Gastroenterol Hepatol Nutr. 2014 Dec;17(4):248-56. doi: 10.5223/pghn.2014.17.4.248. Epub 2014 Dec 31.
7
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.脂肪因子和促炎细胞因子是非酒精性脂肪性肝病发病机制中的关键介质。
World J Gastroenterol. 2014 Dec 28;20(48):18070-91. doi: 10.3748/wjg.v20.i48.18070.
8
Toxicological function of adipose tissue: focus on persistent organic pollutants.脂肪组织的毒理学作用:以持久性有机污染物为重点。
Environ Health Perspect. 2013 Feb;121(2):162-9. doi: 10.1289/ehp.1205485. Epub 2012 Dec 5.
9
Gut microbiota and nonalcoholic fatty liver disease.肠道微生物群与非酒精性脂肪性肝病。
Ann Hepatol. 2012 Jul-Aug;11(4):440-9.
10
Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis.肠漏和肝脏:细菌易位在非酒精性脂肪性肝炎中的作用。
World J Gastroenterol. 2012 Jun 7;18(21):2609-18. doi: 10.3748/wjg.v18.i21.2609.